Spain, July 24 -- Spain based BIOGEN SPAIN, S.L. has secured contract from Gerencia de Atencion Sanitaria de Melilla - Instituto Nacional de Gestion Sanitaria for Pharmaceutical Products - Supply of the exclusive drug "Spinranza of the Biogen Spain company, SL, for the Ingesa Health Care Management in Melilla. The value of the contract is worth 42546680 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....